CLINICAL_TRIALS
trial_result
· 2019-10-23
Clinical Trial Update: Phase II Study of Apremilast (CC-10004) in Adults With in Psoriatic Arthritis [Phase 2]
Summary
Phase II study of Apremilast (CC-10004) in adults with psoriatic arthritis completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Psoriatic Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2019-10-23